SAM #HT942626PE042

Sole-source Sentosa HIV-1 genotyping products and system support for WRAIR

The Defense Health Agency is pursuing a sole-source follow-on with Vela Diagnostics for HIV-1 genotyping products and support at WRAIR. - Requirement: Sentosa kits, consumables, supplies, sequencing systems and sub-components, plus maintenance and repair for the HIV Diagnostics and Reference Lab at the Walter Reed Army Institute of Research (WRAIR). - Manufacturer and platform: Vela Diagnostics’ Sentosa SQ Next Generation Sequencing system and HIV-1 Genotype test. The notice cites FDA approval and proprietary product compatibility as the basis for limiting competition. - Contract approach: Sole-source, firm-fixed-price follow-on procurement; the available information identifies no individual part numbers or quantities. - Period of performance: One-year base period, September 30, 2026–September 29, 2027, with four one-year options, for up to five years through September 29, 2031. - Estimated total value: $2,035,407.89 for the potential five-year period. - Maintenance requirement: Maintain and repair Sentosa systems so instruments meet and maintain CAP standards for clinical testing operations.

Description

The attached document is the Redacted Justification and Approval for the Other than Full anbd Open Competition of theSequencing System for HIV-1 Testing for WRAIR.

View original listing